HC Wainwright Analysts Boost Earnings Estimates for TSE:FRX
Fennec Pharmaceuticals Inc. (TSE:FRX – Free Report) – Stock analysts at HC Wainwright increased their Q2 2025 earnings per share estimates for Fennec Pharmaceuticals in a research note issued on Tuesday, May 20th. HC Wainwright analyst R. Selvaraju now expects that the biopharmaceutical company will post earnings of ($0.10) per share for the quarter, up […]
